




The global biochip products market is projected to reach a value of $15.2 billion by 2026, with a CAGR of 8.4% during the forecast period. Factors such as increasing applications in drug discovery and personalized medicine are driving market growth. North America is expected to dominate the market due to technological advancements and healthcare infrastructure.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Illumina
◍ Thermo Fisher Scientific
◍ Cellix
◍ GE Healthcare
◍ Randox
◍ BioDot
◍ PerkinElmer
◍ Roche
◍ Horiba
◍ Greiner Bio One International
◍ Korea Materials & Analysis
◍ Capitalbio
◍ Dynamic Biosensors
The competitive landscape of the Biochip Products Market includes companies like Illumina, Thermo Fisher Scientific, Cellix, GE Healthcare, Randox, BioDot, PerkinElmer, Roche, Horiba, Greiner Bio One
International, Korea Materials & Analysis, Capitalbio, and Dynamic Biosensors. These companies develop and sell biochip products for various research, diagnostic, and therapeutic applications, which help in driving the growth of the market.
- Illumina reported sales revenue of $4.2 billion in 2020.
- Thermo Fisher Scientific reported sales revenue of $32.2 billion in 2020.
- PerkinElmer reported sales revenue of $3.8 billion in 2020.
Request Sample Report
By Application
◍ Medical
◍ Life Science
◍ Pharmaceutical
◍ Agricultural
By Product
◍ Active Chips
◍ Passive Chips
◍ Other Request Sample Report
Request Sample Report
$ 3.60 Billion